SCHEMBL4432459

SCHEMBL4432459

CCOP(=O)(OCC)C(CC(Oc1ccccc1)Oc1ccccc1)c1ccc(Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.46
POLB P06746 3/20 0.43
L3MBTL1 Q9Y468 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
TP53 P04637 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
GAA P10253 1/20 0.37
NPC1 O15118 1/20 0.37
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4435056 0.87 POLB (0.43) MAPTPOLBL3MBTL1CA12CA1
SCHEMBL4432449 0.86 MAPT (0.47) MAPTPOLBALDH1A1LMNAMEN1
SCHEMBL1833136 0.77 L3MBTL1 (0.48) MAPTPOLBL3MBTL1CA12CA1
SCHEMBL27411963 0.75 MAPT (0.47) MAPTPOLBALDH1A1LMNASLC6A2
SCHEMBL4423967 0.72 L3MBTL1 (0.44) MAPTPOLBL3MBTL1CA12CA1
SCHEMBL4429339 0.72 MAPT (0.44) MAPTPOLBL3MBTL1CA12CA1
SCHEMBL1837398 0.71 POLB (0.64) MAPTPOLBL3MBTL1ALDH1A1LMNA
SCHEMBL10625932 0.70 L3MBTL1 (0.49) MAPTPOLBL3MBTL1CA12CA1
SCHEMBL4428732 0.69 MAPT (0.41) MAPTPOLBL3MBTL1CA12CA1
SCHEMBL4428728 0.69 MAPT (0.41) MAPTPOLBL3MBTL1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7638505-B2 Organophosphoric derivatives useful as anti-parasitic agents UNIVERSITEIT GENT (BE) 2009-12-29 US disclosed
US-20080312190-A1 Such as 3-(N-hydroxyacetamido)-1-(3,4-dichlorophenyl)propylphosphonic acid; Antimalaria agents UNIVERSITEIT GENT (BE) 2008-12-18 US disclosed
EP-1963344-A1 ORGANOPHOSPHORIC DERIVATIVES USEFUL AS ANTI-PARASITIC AGENTS UNIVERSITEIT GENT (BE) 2008-09-03 EP disclosed
WO-2007071453-A1 ORGANOPHOSPHORIC DERIVATIVES USEFUL AS ANTI-PARASITIC AGENTS UNIVERSITEIT GENT (BE) 2007-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312190-A1 Such as 3-(N-hydroxyacetamido)-1-(3,4-dichlorophenyl)propylphosphonic acid; Antimalaria agents SUB1, CBR1, NAT1 MAPT 4756/4885POLB 1824/4885L3MBTL1 635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.